PDF) Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study - The Lancet Rheumatology
Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression | Annals of the Rheumatic Diseases
LS mean change from baseline in (a) PASDAS, (b) DAPSA, and (c) CPDAI.... | Download Scientific Diagram
Validación del índice compuesto DAPSA (Disease Activity for Psoriatic Arthritis) en una cohorte de pacientes con artritis psoriásica en Argentina y determinación de sus valores de corte
Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels et al | Annals of the Rheumatic Diseases
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast - Arias de la Rosa - 2022 -
Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. | Semantic Scholar
Treat to Target in Spondyloarthritis: Myth or Reality? - European Medical Journal
Disease activity categories by Q-DAPSA vs. DAPSA | Download Scientific Diagram
DAPSA (Disease Activity in PSoriatic Arthritis) Score DAPSA = TJ + SJ + CRP + Activity + Pain =
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis | The Journal of Rheumatology
Digital Tools for Assessing Disease Severity in Dermatology. - Abstract - Europe PMC
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study - ScienceDirect
The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology
Radiographic Progression in Psoriatic Arthritis Achieving a Good Response to Treatment: Data Using Newer Composite Indices of Disease Activity - Helliwell - 2018 - Arthritis Care & Research - Wiley Online Library
RheumaHelper - Apps on Google Play
SAT0575 Disease Activity in Psoriatic Arthritis (PSA): Defining Remission and Treatment Success Using the Dapsa-Score: | Request PDF
Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds ...
Dapsa Eng | PDF
Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab - Helliwell - 2014 - Arthritis Care & Research - Wiley Online Library
Disease activity categories by Q-DAPSA vs. DAPSA | Download Scientific Diagram
Correlation of patient‐reported routine assessment of patient index data with clinical measures of disease activity in psoriatic arthritis - Ward - 2022 - International Journal of Rheumatic Diseases - Wiley Online Library
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
